Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

912
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
912
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

999
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
999
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

987
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
987
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.4K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.1K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

896
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study.

Ophthalmology and therapy·2026
Same author

Implementing Cultural Safety and Anti-Racism Training in Master of Public Health Curricula: A Multi-Institutional Case Study and Practical Self-Assessment Tool.

Pedagogy in health promotion·2026
Same author

Examining the impact of naming equity within perinatal substance use and mental health policy: a scoping review.

Health research policy and systems·2025
Same author

Navigating the Hepatic Immune Landscape With Fine Needle Aspiration of the Liver-An Emerging Technique.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

Industry Live Q&A With Cala Health's Alex Kent, Senior Director of Research.

IEEE pulse·2025
Same author

Transgender health content in medical education: a theory-guided systematic review of current training practices and implementation barriers & facilitators.

Advances in health sciences education : theory and practice·2022

Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

1.1K

Managing intractable proctitis and the problematic pouch.

Alex Kent1, Satish Keshav

  • 1Translational Gastroenterology Unit, John Radcliffe Hospital and the University of Oxford, Oxford, UK.

Digestive Diseases (Basel, Switzerland)
|June 28, 2014
PubMed
Summary

Medically refractory proctitis and problematic ileo-anal pouches present management challenges due to unclear causes and limited treatment options. Further research and tailored therapies are crucial for improving patient outcomes in ulcerative colitis.

More Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

2.5K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K

Related Experiment Videos

Last Updated: Apr 27, 2026

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

1.1K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

2.5K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K

Area of Science:

  • Gastroenterology and Inflammatory Bowel Disease research.
  • Clinical management of colorectal conditions.

Background:

  • Proctitis is a common manifestation of ulcerative colitis (UC), with some cases progressing to extensive disease.
  • Medically refractory proctitis and ileo-anal pouch dysfunction pose significant challenges due to limited treatment options and unclear pathogenesis.
  • While colectomy is often avoided for limited proctitis, and ileo-anal pouch surgery generally yields good results, refractory cases require careful consideration.

Purpose of the Study:

  • To review the challenges in managing intractable proctitis and problematic ileo-anal pouches in ulcerative colitis patients.
  • To highlight the importance of a broad differential diagnosis and the need for tailored therapeutic strategies.
  • To emphasize the necessity of supporting clinical trials and meticulous data collection for advancing treatment.

Main Methods:

  • Systematic review of existing literature on proctitis and ileo-anal pouch dysfunction in UC.
  • Analysis of differential diagnoses for refractory proctitis and pouch issues, including infectious, vascular, and iatrogenic causes.
  • Discussion of management strategies, emphasizing individualized therapy and the role of clinical trials.

Main Results:

  • Intractable proctitis and pouch dysfunction often involve complex differential diagnoses, including refractory pouchitis, ischemia, infection, Crohn's disease, and functional disorders.
  • Paucity of high-quality clinical trials complicates evidence-based management decisions.
  • Small case series testing unusual therapies have yielded inconclusive outcomes.

Conclusions:

  • Effective management of intractable proctitis and problematic pouches requires methodical investigation and individualized treatment approaches.
  • There is a critical need for more high-quality clinical trials to guide therapeutic decisions.
  • Meticulous collection and dissemination of data from patient cohorts are essential for advancing the field.